A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.
After nearly a decade of inactivity, Papua New Guinea’s only radiotherapy machine re-started operations six months ago with support from the IAEA, giving renewed hope to thousands of cancer patients ...